Atul Pande, Director at Karuna Therapeutics, Inc. (KRTX), sold 5,000 shares at $110.61 ($577K) on 2021-05-03, disclosed to the SEC on 2021-05-03.
Open-market sale of $577k KRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $120.01 | 2,500 | $300K | 52.0% |
| 2 | $110.61 | 2,500 | $277K | 48.0% |
| Total | $115.31 avg | 5,000 | $577K | 100% |
| Filing → |
| IMVT | SELL | 2026-06-26 | $57K | — | Filing → |
| IMVT | SELL | 2026-06-16 | $51K | — | Filing → |
| IMVT | SELL | 2026-05-20 | $192K | — | Filing → |